CYP17A1 and breast carcinoma: In this study we examine the association between the CYP17 promoter T→C and CYP19 TTTA repeat polymorphisms and female breast cancer by using a family-based design among nuclear families participating in the Metropolitan New York Registry (MNYR), one of the six international centers of the National Cancer Institute's Breast Cancer Family Registry project.